Global & Chile Laparoscopic Devices Market to 2031

The laparoscopic devices market in Chile is experiencing notable growth, driven by the country’s proactive embrace of minimally invasive surgical (MIS) techniques alongside ongoing efforts to modernize its healthcare system. This shift is largely motivated by the well-recognized benefits of MIS, including shorter recovery times, less postoperative pain, and reduced hospital stays. The use of MIS procedures has risen significantly; for example, a review of elective surgeries at a tertiary hospital showed that MIS accounted for 57.3% of cases in 2022, up from just 20.4% in 2015, reflecting a broader regional trend that Chile is actively following. This increase clearly signals a growing demand for laparoscopic devices. Rising obesity rates in Chile are also driving the uptake of bariatric surgery, with a 2023 Ministry of Health report indicating that nearly 38% of adults are obese. Consequently, more patients are opting for laparoscopic weight-loss surgeries, such as gastric bypass, which a 2023 study by the Chilean Society of Surgery noted for their popularity due to faster recovery and reduced risks. This growth has attracted major medical device companies like Medtronic and Johnson & Johnson to expand their laparoscopic product offerings in the country.

Procedures such as laparoscopic appendectomy and cholecystectomy have become routine in Chilean general surgery, demonstrating the versatility and effectiveness of laparoscopy across specialties. In colorectal surgery, laparoscopic techniques have become the global standard for cancer treatment, a practice that Chile is following closely. Similarly, the market for laparoscopic gynecological surgeries is expanding, supported by the high incidence of conditions like ovarian cysts and increasing acceptance of minimally invasive methods. Chile is also integrating advanced endoscopic technologies and minimally invasive techniques in gynecology.

While Chile’s medical device sector largely depends on imports, the country benefits from a solid healthcare infrastructure and an openness to adopting new technologies. The National Digital Health Strategy has accelerated the use of digital tools and connected devices, including in smart operating rooms and robotic-assisted surgeries. For instance, in 2023, Clinica Las Condes introduced Chile’s first AI-driven stroke triage system, exemplifying the market’s embrace of cutting-edge innovations. Additionally, the Instituto de Salud Pública (ISP) is aligning its medical device regulations with global standards, encouraging foreign companies to establish partnerships and bring advanced technologies to the market. Notably, a new regulation introduced in February 2025 (effective February 2026) strengthens sanitary controls on immunohematological reagents, reflecting a broader commitment to patient safety and quality assurance. Together, these regulatory and technological advancements create a favorable environment for continued growth and increasing sophistication in Chile’s laparoscopic devices market. Show more